As of Nov 27
| -0.0065 / -1.42%|
The 2 analysts offering 12-month price forecasts for Synta Pharmaceuticals Corp have a median target of 0.83, with a high estimate of 1.00 and a low estimate of 0.65. The median estimate represents a +83.37% increase from the last price of 0.45.
The current consensus among 3 polled investment analysts is to Hold stock in Synta Pharmaceuticals Corp. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.